24-25 January 2023

2023 European Meeting of ISMPP, London UK

Can we ever have true creativity without true inclusivity? How should the pharmaceutical industry respond to health equity issues? Do digital enhancements improve accessibility or do they just paper over the gap?

Effective innovation happens when we ask big questions. It’s part of what makes Oxford PharmaGenesis an award-winning, independent, global HealthScience communications consultancy. We innovate for clients through our transformative services. We offer expertise in publications, strategic medical communications, informatics and data science, patient engagement, value demonstration, Open Pharma, social media and more.

Join our healthy debate at the 2023 European Meeting of ISMPP and explore new frontiers with Oxford PharmaGenesis.

  • All
  • News
  • Articles
  • Events

'The opportunities are there to take': Executive Director Catherine Hill discusses her journey as a woman in a leadership role at Oxford PharmaGenesis

Thanks to colleagues who took part in the 2022 Great Place to Work survey, Oxford PharmaGenesis is ranked the UK’s no. 6 Best Workplace for Women (large company category). Executive Director Catherine Hill sits on the Oxford PharmaGenesis Board and co-leads the Regional Leadership Team for Europe. Here, she tells us about her own journey […]

Working in and around #MedComms Careers Event

Do you want to feel valued for who you really are? Oxford PharmaGenesis will be at the Working in and around #MedComms careers event! Whether you’re new to medical communications or looking to advance your career, we want to hear about your unique skills and experience. Visit our booth to chat about our award-winning HealthScience consultancy, plus our exciting roles, development opportunities and one-of-a-kind company culture.

Supporting research at the University of Oxford: Oxford PharmaGenesis funds studentship at Green Templeton College to explore the impact of race and ethnicity on emerging digital techniques in dermatology

Oxford PharmaGenesis is delighted to support a funded DPhil studentship in Translational Health Sciences in collaboration with Green Templeton College at the University of Oxford, UK. The studentship will examine the importance of diversity in dermatology, particularly when applying emerging techniques in artificial intelligence and machine learning. Applications are now open. Please help to spread […]

The MM+M Agency 100 report: Oxford PharmaGenesis recognized as industry leader for the second year running

For the second year running, media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in its Agency 100 report – the annual definitive ‘who’s who’ ranking of the healthcare sector’s top marketing firms in North America.

Promoting diversity in clinical trials: Oxford PharmaGenesis sponsors latest CISCRP campaign

Oxford PharmaGenesis is proud to sponsor the latest CISCRP clinical trials education campaign to raise awareness and understanding of clinical research among minority urban communities in cities across the USA and among the wider general public.

Public health initiative MS Brain Health shortlisted for Communiqué 'Excellence' Award

Oxford PharmaGenesis has been shortlisted for the Communiqué Awards 2022 for the Award for Excellence in Public Health Communications for MS Brain Health, on behalf of Oxford Health Policy Forum. This global policy initiative has changed the way that leading multiple sclerosis (MS) experts view best practice in MS care.